EGFR and glioblastoma: This study shows that the specific dPCR assay using LNA-hydrolysis probes from UPL® is a reliable and simple method to simultaneously detect an EGFR amplification and EGFRvIII variant, and this can be used in clinical practice in glioblastoma.